Banka BioLoo Limited (BANKA) has announced its financial results for Quarter 2 of FY 2026-27. The company reported a significant improvement in its standalone performance, with total income rising 24.5% year-on-year to ₹1,656 lakh. The EBITDA margin stood at 9.5% compared to a loss of ₹39.5 lakh in the same period last year. The company’s standalone profit after tax (PAT) surged to ₹41.6 lakh, reversing the loss of ₹110.4 lakh in the previous year. This positive trend continues into the first half of the fiscal year, with H1 PAT reaching ₹78.7 lakh against a loss of ₹96.8 lakh in the same period last year.

Financial Performance

The financial performance for Q2 FY26-27 showcases the company’s strategic shift towards more profitable private clients, resulting in better cash flow management and a faster turnaround. This strategic pivot is evident in the improved financial metrics, with total income for the standalone business up by 24.5% year-on-year. The EBITDA margin improved significantly, reflecting operational efficiencies and cost management. The company’s PAT turnaround is particularly notable, with a substantial increase from a loss of ₹110.4 lakh to a profit of ₹41.6 lakh.

Order Book and Outlook

The order book for Banka BioLoo Limited remains robust, with ₹83.4 crore unexecuted as of September 30, 2026. The company has secured ₹16 crore in new orders during Q2 FY26-27, with 100% of these bookings coming from private clients. This trend indicates a positive shift towards higher-margin, private sector contracts, which is expected to further enhance the company’s financial performance in the coming quarters.

As Banka BioLoo Limited continues to expand its operations and secure new contracts, the company remains focused on converting its platform into recurring revenue, cash, and sustainable profit. With a strong order book and a strategic shift towards more profitable clients, BANKA is well-positioned to capitalize on growth opportunities in the water, sanitation, and hygiene sector.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Banka BioLoo Limited

Banka BioLoo Limited belongs to the Industrials › Pollution & Treatment Controls sector. Here’s a quick read on where the business and the stock stand today.

Banka holds in the upper half of its 52-week range, a sign the market backs the stock. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. No meaningful dividend — total return is entirely dependent on capital appreciation. The stock trades at 76% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Price climbs recently despite 10.5% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Banka BioLoo Limited.